nodes	percent_of_prediction	percent_of_DWPC	metapath
Tacrolimus—atopic dermatitis—allergic rhinitis	0.657	1	CtDrD
Tacrolimus—ABCB1—Desloratadine—allergic rhinitis	0.0206	0.107	CbGbCtD
Tacrolimus—CYP3A7—Hydrocortisone—allergic rhinitis	0.0135	0.0701	CbGbCtD
Tacrolimus—CYP3A7-CYP3A51P—Hydrocortisone—allergic rhinitis	0.0135	0.0701	CbGbCtD
Tacrolimus—CYP3A4—Flunisolide—allergic rhinitis	0.0123	0.0642	CbGbCtD
Tacrolimus—ABCB1—Loratadine—allergic rhinitis	0.0118	0.0615	CbGbCtD
Tacrolimus—CYP3A4—Olopatadine—allergic rhinitis	0.0116	0.0603	CbGbCtD
Tacrolimus—ABCB1—Methylprednisolone—allergic rhinitis	0.0108	0.0563	CbGbCtD
Tacrolimus—CYP3A5—Hydrocortisone—allergic rhinitis	0.0101	0.0526	CbGbCtD
Tacrolimus—CYP3A7-CYP3A51P—Dexamethasone—allergic rhinitis	0.00838	0.0436	CbGbCtD
Tacrolimus—CYP3A7—Dexamethasone—allergic rhinitis	0.00838	0.0436	CbGbCtD
Tacrolimus—CYP3A4—Montelukast—allergic rhinitis	0.00709	0.0369	CbGbCtD
Tacrolimus—CYP3A4—Loratadine—allergic rhinitis	0.00709	0.0369	CbGbCtD
Tacrolimus—ABCB1—Betamethasone—allergic rhinitis	0.00704	0.0366	CbGbCtD
Tacrolimus—ABCB1—Prednisolone—allergic rhinitis	0.00694	0.0361	CbGbCtD
Tacrolimus—ABCB1—Hydrocortisone—allergic rhinitis	0.00658	0.0342	CbGbCtD
Tacrolimus—CYP3A4—Methylprednisolone—allergic rhinitis	0.00648	0.0337	CbGbCtD
Tacrolimus—CYP3A5—Dexamethasone—allergic rhinitis	0.00629	0.0327	CbGbCtD
Tacrolimus—CYP3A4—Triamcinolone—allergic rhinitis	0.00491	0.0255	CbGbCtD
Tacrolimus—CYP3A4—Betamethasone—allergic rhinitis	0.00422	0.0219	CbGbCtD
Tacrolimus—CYP3A4—Prednisolone—allergic rhinitis	0.00416	0.0216	CbGbCtD
Tacrolimus—ABCB1—Dexamethasone—allergic rhinitis	0.00409	0.0213	CbGbCtD
Tacrolimus—CYP3A4—Hydrocortisone—allergic rhinitis	0.00394	0.0205	CbGbCtD
Tacrolimus—ORM1—saliva—allergic rhinitis	0.00249	0.113	CbGeAlD
Tacrolimus—CYP3A4—Dexamethasone—allergic rhinitis	0.00245	0.0128	CbGbCtD
Tacrolimus—ABCA5—eye—allergic rhinitis	0.00171	0.0774	CbGeAlD
Tacrolimus—ABCA5—bronchus—allergic rhinitis	0.00154	0.0697	CbGeAlD
Tacrolimus—ABCA5—trachea—allergic rhinitis	0.00138	0.0626	CbGeAlD
Tacrolimus—PPP3CA—respiratory system—allergic rhinitis	0.00126	0.0572	CbGeAlD
Tacrolimus—PPP3CA—bronchus—allergic rhinitis	0.00104	0.0471	CbGeAlD
Tacrolimus—ABCA5—lung—allergic rhinitis	0.000991	0.045	CbGeAlD
Tacrolimus—PPP3CA—trachea—allergic rhinitis	0.000932	0.0423	CbGeAlD
Tacrolimus—MTOR—respiratory system—allergic rhinitis	0.000931	0.0423	CbGeAlD
Tacrolimus—MTOR—eye—allergic rhinitis	0.000851	0.0386	CbGeAlD
Tacrolimus—FKBP1A—respiratory system—allergic rhinitis	0.000838	0.038	CbGeAlD
Tacrolimus—MTOR—TSLP Signaling Pathway—TSLP—allergic rhinitis	0.000837	0.0685	CbGpPWpGaD
Tacrolimus—MTOR—epithelium—allergic rhinitis	0.000778	0.0353	CbGeAlD
Tacrolimus—FKBP1A—eye—allergic rhinitis	0.000765	0.0347	CbGeAlD
Tacrolimus—MTOR—skin of body—allergic rhinitis	0.00074	0.0336	CbGeAlD
Tacrolimus—FKBP1A—epithelium—allergic rhinitis	0.0007	0.0318	CbGeAlD
Tacrolimus—FKBP1A—bronchus—allergic rhinitis	0.000689	0.0313	CbGeAlD
Tacrolimus—PPP3CA—lung—allergic rhinitis	0.000669	0.0304	CbGeAlD
Tacrolimus—FKBP1A—skin of body—allergic rhinitis	0.000666	0.0302	CbGeAlD
Tacrolimus—FKBP1A—trachea—allergic rhinitis	0.000619	0.0281	CbGeAlD
Tacrolimus—MTOR—lung—allergic rhinitis	0.000494	0.0224	CbGeAlD
Tacrolimus—FKBP1A—lung—allergic rhinitis	0.000445	0.0202	CbGeAlD
Tacrolimus—FKBP1A—Calcium signaling in the CD4+ TCR pathway—IL4—allergic rhinitis	0.000389	0.0319	CbGpPWpGaD
Tacrolimus—PPP3CA—Fc epsilon receptor (FCERI) signaling—MS4A2—allergic rhinitis	0.000381	0.0312	CbGpPWpGaD
Tacrolimus—MTOR—Type II diabetes mellitus—ADIPOQ—allergic rhinitis	0.000372	0.0304	CbGpPWpGaD
Tacrolimus—MTOR—CXCR3-mediated signaling events—CCL11—allergic rhinitis	0.000367	0.03	CbGpPWpGaD
Tacrolimus—CYP3A5—respiratory system—allergic rhinitis	0.000365	0.0166	CbGeAlD
Tacrolimus—FKBP1A—TGF-beta receptor signaling activates SMADs—SMAD3—allergic rhinitis	0.000356	0.0291	CbGpPWpGaD
Tacrolimus—ORM1—lung—allergic rhinitis	0.000348	0.0158	CbGeAlD
Tacrolimus—MTOR—TSLP Signaling Pathway—CCL11—allergic rhinitis	0.00031	0.0254	CbGpPWpGaD
Tacrolimus—FKBP1A—TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition)—TGFB1—allergic rhinitis	0.000262	0.0215	CbGpPWpGaD
Tacrolimus—PPP3CA—T-Cell Receptor and Co-stimulatory Signaling—NFKB1—allergic rhinitis	0.000253	0.0207	CbGpPWpGaD
Tacrolimus—MTOR—IL4-mediated signaling events—CCL11—allergic rhinitis	0.000248	0.0203	CbGpPWpGaD
Tacrolimus—FKBP1A—TGF-beta receptor signaling—SMAD3—allergic rhinitis	0.000241	0.0198	CbGpPWpGaD
Tacrolimus—FKBP1A—TGF-beta Receptor Signaling—SMAD3—allergic rhinitis	0.000234	0.0192	CbGpPWpGaD
Tacrolimus—PPP3CA—Initiation of transcription and translation elongation at the HIV-1 LTR—NFKB1—allergic rhinitis	0.000233	0.0191	CbGpPWpGaD
Tacrolimus—MTOR—Extracellular vesicle-mediated signaling in recipient cells—SMAD3—allergic rhinitis	0.000211	0.0173	CbGpPWpGaD
Tacrolimus—ABCB1—respiratory system—allergic rhinitis	0.000194	0.0088	CbGeAlD
Tacrolimus—CYP3A5—lung—allergic rhinitis	0.000194	0.00879	CbGeAlD
Tacrolimus—FKBP1A—Loss of Function of SMAD2/3 in Cancer—SMAD3—allergic rhinitis	0.00019	0.0156	CbGpPWpGaD
Tacrolimus—FKBP1A—ALK1 signaling events—TGFB1—allergic rhinitis	0.000178	0.0146	CbGpPWpGaD
Tacrolimus—MTOR—IL4-mediated signaling events—IL5—allergic rhinitis	0.000168	0.0137	CbGpPWpGaD
Tacrolimus—MTOR—Fc epsilon receptor (FCERI) signaling—MS4A2—allergic rhinitis	0.000166	0.0136	CbGpPWpGaD
Tacrolimus—PPP3CA—Spinal Cord Injury—IL4—allergic rhinitis	0.000163	0.0134	CbGpPWpGaD
Tacrolimus—ABCB1—epithelium—allergic rhinitis	0.000162	0.00735	CbGeAlD
Tacrolimus—PPP3CA—Cardiac Hypertrophic Response—NFKB1—allergic rhinitis	0.000151	0.0124	CbGpPWpGaD
Tacrolimus—FKBP1A—TGF-beta receptor signaling activates SMADs—TGFB1—allergic rhinitis	0.000151	0.0123	CbGpPWpGaD
Tacrolimus—MTOR—AMPK Signaling—ADIPOQ—allergic rhinitis	0.000149	0.0122	CbGpPWpGaD
Tacrolimus—PPP3CA—Innate Immune System—MS4A2—allergic rhinitis	0.000148	0.0121	CbGpPWpGaD
Tacrolimus—ABCB1—trachea—allergic rhinitis	0.000143	0.0065	CbGeAlD
Tacrolimus—PPP3CA—Spinal Cord Injury—ICAM1—allergic rhinitis	0.00013	0.0106	CbGpPWpGaD
Tacrolimus—PPP3CA—BCR signaling pathway—NFKB1—allergic rhinitis	0.000129	0.0106	CbGpPWpGaD
Tacrolimus—FKBP1A—Spinal Cord Injury—IL4—allergic rhinitis	0.000127	0.0104	CbGpPWpGaD
Tacrolimus—PPP3CA—Cardiac Hypertrophic Response—TGFB1—allergic rhinitis	0.000126	0.0103	CbGpPWpGaD
Tacrolimus—PPP3CA—C-MYB transcription factor network—CD4—allergic rhinitis	0.000125	0.0102	CbGpPWpGaD
Tacrolimus—MTOR—IL4-mediated signaling events—IL10—allergic rhinitis	0.000123	0.01	CbGpPWpGaD
Tacrolimus—MTOR—IL12-mediated signaling events—IL4—allergic rhinitis	0.000122	0.01	CbGpPWpGaD
Tacrolimus—MTOR—Costimulation by the CD28 family—HLA-DQB1—allergic rhinitis	0.000121	0.00987	CbGpPWpGaD
Tacrolimus—MTOR—IL4-mediated signaling events—IL4—allergic rhinitis	0.000119	0.00976	CbGpPWpGaD
Tacrolimus—FKBP1A—TGF-beta Receptor Signaling—NFKB1—allergic rhinitis	0.000119	0.00975	CbGpPWpGaD
Tacrolimus—MTOR—Regulation of Telomerase—SMAD3—allergic rhinitis	0.00011	0.00897	CbGpPWpGaD
Tacrolimus—PPP3CA—MicroRNAs in cardiomyocyte hypertrophy—NFKB1—allergic rhinitis	0.000108	0.00883	CbGpPWpGaD
Tacrolimus—MTOR—RANKL/RANK Signaling Pathway—ICAM1—allergic rhinitis	0.000104	0.00853	CbGpPWpGaD
Tacrolimus—ABCB1—lung—allergic rhinitis	0.000103	0.00467	CbGeAlD
Tacrolimus—FKBP1A—TGF-beta receptor signaling—TGFB1—allergic rhinitis	0.000102	0.00837	CbGpPWpGaD
Tacrolimus—FKBP1A—Spinal Cord Injury—ICAM1—allergic rhinitis	0.000101	0.00824	CbGpPWpGaD
Tacrolimus—FKBP1A—TGF-beta Receptor Signaling—TGFB1—allergic rhinitis	9.92e-05	0.00812	CbGpPWpGaD
Tacrolimus—MTOR—IL2 signaling events mediated by PI3K—NFKB1—allergic rhinitis	9.06e-05	0.00742	CbGpPWpGaD
Tacrolimus—PPP3CA—MicroRNAs in cardiomyocyte hypertrophy—TGFB1—allergic rhinitis	8.98e-05	0.00735	CbGpPWpGaD
Tacrolimus—MTOR—Extracellular vesicle-mediated signaling in recipient cells—TGFB1—allergic rhinitis	8.93e-05	0.00731	CbGpPWpGaD
Tacrolimus—PPP3CA—Immune System—MS4A2—allergic rhinitis	8.63e-05	0.00707	CbGpPWpGaD
Tacrolimus—ABCB1—Allograft Rejection—FOXP3—allergic rhinitis	8.12e-05	0.00665	CbGpPWpGaD
Tacrolimus—FKBP1A—Loss of Function of SMAD2/3 in Cancer—TGFB1—allergic rhinitis	8.06e-05	0.0066	CbGpPWpGaD
Tacrolimus—PPP3CA—Signaling by GPCR—PTGDR2—allergic rhinitis	8.03e-05	0.00658	CbGpPWpGaD
Tacrolimus—MTOR—Senescence and Autophagy in Cancer—SMAD3—allergic rhinitis	7.74e-05	0.00634	CbGpPWpGaD
Tacrolimus—MTOR—TSLP Signaling Pathway—NFKB1—allergic rhinitis	7.48e-05	0.00613	CbGpPWpGaD
Tacrolimus—ABCB1—Allograft Rejection—HLA-G—allergic rhinitis	7.37e-05	0.00604	CbGpPWpGaD
Tacrolimus—MTOR—IL12-mediated signaling events—CD4—allergic rhinitis	7.14e-05	0.00585	CbGpPWpGaD
Tacrolimus—ABCB1—Allograft Rejection—IL13—allergic rhinitis	6.95e-05	0.00569	CbGpPWpGaD
Tacrolimus—PPP3CA—Spinal Cord Injury—TGFB1—allergic rhinitis	6.84e-05	0.0056	CbGpPWpGaD
Tacrolimus—MTOR—RANKL/RANK Signaling Pathway—NFKB1—allergic rhinitis	6.6e-05	0.0054	CbGpPWpGaD
Tacrolimus—MTOR—Cardiac Hypertrophic Response—NFKB1—allergic rhinitis	6.6e-05	0.0054	CbGpPWpGaD
Tacrolimus—MTOR—Costimulation by the CD28 family—CD4—allergic rhinitis	6.46e-05	0.00529	CbGpPWpGaD
Tacrolimus—MTOR—Innate Immune System—MS4A2—allergic rhinitis	6.46e-05	0.00529	CbGpPWpGaD
Tacrolimus—ABCB1—Allograft Rejection—IL17A—allergic rhinitis	6.39e-05	0.00523	CbGpPWpGaD
Tacrolimus—PPP3CA—Signaling by GPCR—CYSLTR1—allergic rhinitis	6.3e-05	0.00516	CbGpPWpGaD
Tacrolimus—PPP3CA—MAPK Signaling Pathway—NFKB1—allergic rhinitis	6.19e-05	0.00507	CbGpPWpGaD
Tacrolimus—MTOR—IL12-mediated signaling events—NFKB1—allergic rhinitis	6.16e-05	0.00504	CbGpPWpGaD
Tacrolimus—PPP3CA—Signaling by GPCR—CCL11—allergic rhinitis	6.09e-05	0.00498	CbGpPWpGaD
Tacrolimus—ABCB1—Allograft Rejection—IL5—allergic rhinitis	5.94e-05	0.00487	CbGpPWpGaD
Tacrolimus—PPP3CA—Fc epsilon receptor (FCERI) signaling—NFKB1—allergic rhinitis	5.94e-05	0.00486	CbGpPWpGaD
Tacrolimus—MTOR—Oncostatin M Signaling Pathway—NFKB1—allergic rhinitis	5.77e-05	0.00473	CbGpPWpGaD
Tacrolimus—ALB—Folate Metabolism—IL4—allergic rhinitis	5.57e-05	0.00456	CbGpPWpGaD
Tacrolimus—MTOR—Regulation of Telomerase—NFKB1—allergic rhinitis	5.57e-05	0.00456	CbGpPWpGaD
Tacrolimus—MTOR—Cardiac Hypertrophic Response—TGFB1—allergic rhinitis	5.5e-05	0.0045	CbGpPWpGaD
Tacrolimus—MTOR—CXCR4-mediated signaling events—CD4—allergic rhinitis	5.46e-05	0.00447	CbGpPWpGaD
Tacrolimus—ALB—Vitamin B12 Metabolism—ICAM1—allergic rhinitis	5.44e-05	0.00445	CbGpPWpGaD
Tacrolimus—FKBP1A—Spinal Cord Injury—TGFB1—allergic rhinitis	5.31e-05	0.00434	CbGpPWpGaD
Tacrolimus—PPP3CA—MAPK Signaling Pathway—TGFB1—allergic rhinitis	5.16e-05	0.00422	CbGpPWpGaD
Tacrolimus—MTOR—Leptin signaling pathway—NFKB1—allergic rhinitis	5.15e-05	0.00422	CbGpPWpGaD
Tacrolimus—ABCB1—HIF-1-alpha transcription factor network—SMAD3—allergic rhinitis	4.83e-05	0.00395	CbGpPWpGaD
Tacrolimus—PPP3CA—Signaling Pathways—PTGDR2—allergic rhinitis	4.75e-05	0.00389	CbGpPWpGaD
Tacrolimus—MTOR—MicroRNAs in cardiomyocyte hypertrophy—NFKB1—allergic rhinitis	4.7e-05	0.00385	CbGpPWpGaD
Tacrolimus—PPP3CA—Immune System—HLA-G—allergic rhinitis	4.66e-05	0.00382	CbGpPWpGaD
Tacrolimus—MTOR—Regulation of Telomerase—TGFB1—allergic rhinitis	4.64e-05	0.0038	CbGpPWpGaD
Tacrolimus—ABCB1—Allograft Rejection—HLA-DQB1—allergic rhinitis	4.6e-05	0.00377	CbGpPWpGaD
Tacrolimus—ALB—Folate Metabolism—ICAM1—allergic rhinitis	4.43e-05	0.00362	CbGpPWpGaD
Tacrolimus—PPP3CA—Signaling by GPCR—TAC1—allergic rhinitis	4.42e-05	0.00362	CbGpPWpGaD
Tacrolimus—ABCB1—Allograft Rejection—IL10—allergic rhinitis	4.35e-05	0.00356	CbGpPWpGaD
Tacrolimus—FKBP1A—Integrated Pancreatic Cancer Pathway—NFKB1—allergic rhinitis	4.33e-05	0.00355	CbGpPWpGaD
Tacrolimus—ABCB1—Allograft Rejection—IL4—allergic rhinitis	4.23e-05	0.00346	CbGpPWpGaD
Tacrolimus—PPP3CA—Signaling by GPCR—IL5—allergic rhinitis	4.11e-05	0.00337	CbGpPWpGaD
Tacrolimus—MTOR—MicroRNAs in cardiomyocyte hypertrophy—TGFB1—allergic rhinitis	3.92e-05	0.00321	CbGpPWpGaD
Tacrolimus—MTOR—Immune System—MS4A2—allergic rhinitis	3.76e-05	0.00308	CbGpPWpGaD
Tacrolimus—PPP3CA—Immune System—IL5—allergic rhinitis	3.76e-05	0.00308	CbGpPWpGaD
Tacrolimus—PPP3CA—Signaling Pathways—CYSLTR1—allergic rhinitis	3.72e-05	0.00305	CbGpPWpGaD
Tacrolimus—FKBP1A—Signaling Pathways—PTGDR2—allergic rhinitis	3.68e-05	0.00301	CbGpPWpGaD
Tacrolimus—FKBP1A—Integrated Pancreatic Cancer Pathway—TGFB1—allergic rhinitis	3.61e-05	0.00296	CbGpPWpGaD
Tacrolimus—PPP3CA—Signaling Pathways—CCL11—allergic rhinitis	3.6e-05	0.00294	CbGpPWpGaD
Tacrolimus—ALB—Selenium Micronutrient Network—ICAM1—allergic rhinitis	3.52e-05	0.00288	CbGpPWpGaD
Tacrolimus—ALB—Vitamin B12 Metabolism—NFKB1—allergic rhinitis	3.44e-05	0.00282	CbGpPWpGaD
Tacrolimus—MTOR—Adaptive Immune System—HLA-G—allergic rhinitis	3.35e-05	0.00274	CbGpPWpGaD
Tacrolimus—MTOR—Senescence and Autophagy in Cancer—TGFB1—allergic rhinitis	3.28e-05	0.00268	CbGpPWpGaD
Tacrolimus—Rash—Montelukast—allergic rhinitis	3.15e-05	0.000271	CcSEcCtD
Tacrolimus—Dermatitis—Montelukast—allergic rhinitis	3.15e-05	0.000271	CcSEcCtD
Tacrolimus—Ill-defined disorder—Prednisolone—allergic rhinitis	3.14e-05	0.00027	CcSEcCtD
Tacrolimus—Headache—Montelukast—allergic rhinitis	3.13e-05	0.00027	CcSEcCtD
Tacrolimus—Visual impairment—Betamethasone—allergic rhinitis	3.13e-05	0.000269	CcSEcCtD
Tacrolimus—Visual impairment—Dexamethasone—allergic rhinitis	3.13e-05	0.000269	CcSEcCtD
Tacrolimus—Mental disorder—Methylprednisolone—allergic rhinitis	3.12e-05	0.000269	CcSEcCtD
Tacrolimus—Erythema—Triamcinolone—allergic rhinitis	3.11e-05	0.000268	CcSEcCtD
Tacrolimus—Malnutrition—Methylprednisolone—allergic rhinitis	3.1e-05	0.000267	CcSEcCtD
Tacrolimus—Erythema—Methylprednisolone—allergic rhinitis	3.1e-05	0.000267	CcSEcCtD
Tacrolimus—Ill-defined disorder—Hydrocortisone—allergic rhinitis	3.07e-05	0.000264	CcSEcCtD
Tacrolimus—MTOR—BDNF signaling pathway—NFKB1—allergic rhinitis	3.06e-05	0.0025	CbGpPWpGaD
Tacrolimus—Malaise—Prednisolone—allergic rhinitis	3.05e-05	0.000263	CcSEcCtD
Tacrolimus—Dysgeusia—Triamcinolone—allergic rhinitis	3.05e-05	0.000262	CcSEcCtD
Tacrolimus—Vertigo—Prednisolone—allergic rhinitis	3.04e-05	0.000262	CcSEcCtD
Tacrolimus—Syncope—Prednisolone—allergic rhinitis	3.03e-05	0.000261	CcSEcCtD
Tacrolimus—Eye disorder—Betamethasone—allergic rhinitis	3.03e-05	0.000261	CcSEcCtD
Tacrolimus—Eye disorder—Dexamethasone—allergic rhinitis	3.03e-05	0.000261	CcSEcCtD
Tacrolimus—Back pain—Triamcinolone—allergic rhinitis	3.01e-05	0.000259	CcSEcCtD
Tacrolimus—Malaise—Hydrocortisone—allergic rhinitis	2.98e-05	0.000257	CcSEcCtD
Tacrolimus—ALB—Platelet activation, signaling and aggregation—IL5—allergic rhinitis	2.98e-05	0.00244	CbGpPWpGaD
Tacrolimus—Loss of consciousness—Prednisolone—allergic rhinitis	2.97e-05	0.000256	CcSEcCtD
Tacrolimus—Vertigo—Hydrocortisone—allergic rhinitis	2.97e-05	0.000256	CcSEcCtD
Tacrolimus—Nausea—Montelukast—allergic rhinitis	2.97e-05	0.000256	CcSEcCtD
Tacrolimus—Syncope—Hydrocortisone—allergic rhinitis	2.96e-05	0.000255	CcSEcCtD
Tacrolimus—Angiopathy—Betamethasone—allergic rhinitis	2.94e-05	0.000253	CcSEcCtD
Tacrolimus—Angiopathy—Dexamethasone—allergic rhinitis	2.94e-05	0.000253	CcSEcCtD
Tacrolimus—MTOR—Integrated Breast Cancer Pathway—NFKB1—allergic rhinitis	2.94e-05	0.00241	CbGpPWpGaD
Tacrolimus—Convulsion—Prednisolone—allergic rhinitis	2.93e-05	0.000253	CcSEcCtD
Tacrolimus—Hypertension—Prednisolone—allergic rhinitis	2.92e-05	0.000252	CcSEcCtD
Tacrolimus—PPP3CA—Immune System—HLA-DQB1—allergic rhinitis	2.91e-05	0.00238	CbGpPWpGaD
Tacrolimus—Loss of consciousness—Hydrocortisone—allergic rhinitis	2.9e-05	0.00025	CcSEcCtD
Tacrolimus—Arrhythmia—Betamethasone—allergic rhinitis	2.9e-05	0.00025	CcSEcCtD
Tacrolimus—Arrhythmia—Dexamethasone—allergic rhinitis	2.9e-05	0.00025	CcSEcCtD
Tacrolimus—FKBP1A—Signaling Pathways—CYSLTR1—allergic rhinitis	2.89e-05	0.00236	CbGpPWpGaD
Tacrolimus—Ill-defined disorder—Triamcinolone—allergic rhinitis	2.89e-05	0.000249	CcSEcCtD
Tacrolimus—Ill-defined disorder—Methylprednisolone—allergic rhinitis	2.88e-05	0.000248	CcSEcCtD
Tacrolimus—Alopecia—Betamethasone—allergic rhinitis	2.87e-05	0.000247	CcSEcCtD
Tacrolimus—Alopecia—Dexamethasone—allergic rhinitis	2.87e-05	0.000247	CcSEcCtD
Tacrolimus—Convulsion—Hydrocortisone—allergic rhinitis	2.86e-05	0.000247	CcSEcCtD
Tacrolimus—Hypertension—Hydrocortisone—allergic rhinitis	2.85e-05	0.000246	CcSEcCtD
Tacrolimus—Discomfort—Prednisolone—allergic rhinitis	2.85e-05	0.000245	CcSEcCtD
Tacrolimus—Erythema—Betamethasone—allergic rhinitis	2.82e-05	0.000243	CcSEcCtD
Tacrolimus—Erythema—Dexamethasone—allergic rhinitis	2.82e-05	0.000243	CcSEcCtD
Tacrolimus—Myalgia—Hydrocortisone—allergic rhinitis	2.81e-05	0.000242	CcSEcCtD
Tacrolimus—Malaise—Triamcinolone—allergic rhinitis	2.81e-05	0.000242	CcSEcCtD
Tacrolimus—Anxiety—Hydrocortisone—allergic rhinitis	2.8e-05	0.000242	CcSEcCtD
Tacrolimus—ALB—Folate Metabolism—NFKB1—allergic rhinitis	2.8e-05	0.00229	CbGpPWpGaD
Tacrolimus—Malaise—Methylprednisolone—allergic rhinitis	2.8e-05	0.000241	CcSEcCtD
Tacrolimus—Vertigo—Triamcinolone—allergic rhinitis	2.8e-05	0.000241	CcSEcCtD
Tacrolimus—Unspecified disorder of skin and subcutaneous tissue—Hydrocortisone—allergic rhinitis	2.79e-05	0.000241	CcSEcCtD
Tacrolimus—Syncope—Triamcinolone—allergic rhinitis	2.79e-05	0.00024	CcSEcCtD
Tacrolimus—Vertigo—Methylprednisolone—allergic rhinitis	2.79e-05	0.00024	CcSEcCtD
Tacrolimus—FKBP1A—Signaling Pathways—CCL11—allergic rhinitis	2.79e-05	0.00228	CbGpPWpGaD
Tacrolimus—Syncope—Methylprednisolone—allergic rhinitis	2.78e-05	0.00024	CcSEcCtD
Tacrolimus—Discomfort—Hydrocortisone—allergic rhinitis	2.78e-05	0.000239	CcSEcCtD
Tacrolimus—Oedema—Prednisolone—allergic rhinitis	2.76e-05	0.000238	CcSEcCtD
Tacrolimus—Anaphylactic shock—Prednisolone—allergic rhinitis	2.76e-05	0.000238	CcSEcCtD
Tacrolimus—Loss of consciousness—Triamcinolone—allergic rhinitis	2.73e-05	0.000236	CcSEcCtD
Tacrolimus—Loss of consciousness—Methylprednisolone—allergic rhinitis	2.73e-05	0.000235	CcSEcCtD
Tacrolimus—Shock—Prednisolone—allergic rhinitis	2.72e-05	0.000234	CcSEcCtD
Tacrolimus—Cough—Triamcinolone—allergic rhinitis	2.72e-05	0.000234	CcSEcCtD
Tacrolimus—MTOR—Downstream signaling events of B Cell Receptor (BCR)—NFKB1—allergic rhinitis	2.71e-05	0.00222	CbGpPWpGaD
Tacrolimus—Anaphylactic shock—Hydrocortisone—allergic rhinitis	2.7e-05	0.000232	CcSEcCtD
Tacrolimus—Oedema—Hydrocortisone—allergic rhinitis	2.7e-05	0.000232	CcSEcCtD
Tacrolimus—Convulsion—Triamcinolone—allergic rhinitis	2.7e-05	0.000232	CcSEcCtD
Tacrolimus—Tachycardia—Prednisolone—allergic rhinitis	2.7e-05	0.000232	CcSEcCtD
Tacrolimus—Convulsion—Methylprednisolone—allergic rhinitis	2.69e-05	0.000232	CcSEcCtD
Tacrolimus—Hypertension—Triamcinolone—allergic rhinitis	2.69e-05	0.000231	CcSEcCtD
Tacrolimus—Hypertension—Methylprednisolone—allergic rhinitis	2.68e-05	0.000231	CcSEcCtD
Tacrolimus—Infection—Hydrocortisone—allergic rhinitis	2.68e-05	0.000231	CcSEcCtD
Tacrolimus—PPP3CA—Innate Immune System—CD4—allergic rhinitis	2.68e-05	0.00219	CbGpPWpGaD
Tacrolimus—Hyperhidrosis—Prednisolone—allergic rhinitis	2.67e-05	0.00023	CcSEcCtD
Tacrolimus—Shock—Hydrocortisone—allergic rhinitis	2.65e-05	0.000229	CcSEcCtD
Tacrolimus—Myalgia—Triamcinolone—allergic rhinitis	2.65e-05	0.000228	CcSEcCtD
Tacrolimus—Nervous system disorder—Hydrocortisone—allergic rhinitis	2.64e-05	0.000228	CcSEcCtD
Tacrolimus—Myalgia—Methylprednisolone—allergic rhinitis	2.64e-05	0.000228	CcSEcCtD
Tacrolimus—Arthralgia—Methylprednisolone—allergic rhinitis	2.64e-05	0.000228	CcSEcCtD
Tacrolimus—Anxiety—Methylprednisolone—allergic rhinitis	2.63e-05	0.000227	CcSEcCtD
Tacrolimus—Tachycardia—Hydrocortisone—allergic rhinitis	2.63e-05	0.000227	CcSEcCtD
Tacrolimus—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—allergic rhinitis	2.62e-05	0.000226	CcSEcCtD
Tacrolimus—Skin disorder—Hydrocortisone—allergic rhinitis	2.62e-05	0.000226	CcSEcCtD
Tacrolimus—Ill-defined disorder—Betamethasone—allergic rhinitis	2.62e-05	0.000226	CcSEcCtD
Tacrolimus—Ill-defined disorder—Dexamethasone—allergic rhinitis	2.62e-05	0.000226	CcSEcCtD
Tacrolimus—Discomfort—Triamcinolone—allergic rhinitis	2.62e-05	0.000225	CcSEcCtD
Tacrolimus—PPP3CA—Signaling Pathways—TAC1—allergic rhinitis	2.61e-05	0.00214	CbGpPWpGaD
Tacrolimus—Discomfort—Methylprednisolone—allergic rhinitis	2.61e-05	0.000225	CcSEcCtD
Tacrolimus—Hyperhidrosis—Hydrocortisone—allergic rhinitis	2.61e-05	0.000225	CcSEcCtD
Tacrolimus—Dry mouth—Triamcinolone—allergic rhinitis	2.59e-05	0.000223	CcSEcCtD
Tacrolimus—MTOR—Fc epsilon receptor (FCERI) signaling—NFKB1—allergic rhinitis	2.59e-05	0.00212	CbGpPWpGaD
Tacrolimus—Anorexia—Hydrocortisone—allergic rhinitis	2.57e-05	0.000221	CcSEcCtD
Tacrolimus—Confusional state—Methylprednisolone—allergic rhinitis	2.55e-05	0.00022	CcSEcCtD
Tacrolimus—Malaise—Dexamethasone—allergic rhinitis	2.55e-05	0.000219	CcSEcCtD
Tacrolimus—Malaise—Betamethasone—allergic rhinitis	2.55e-05	0.000219	CcSEcCtD
Tacrolimus—Anaphylactic shock—Triamcinolone—allergic rhinitis	2.54e-05	0.000219	CcSEcCtD
Tacrolimus—Oedema—Triamcinolone—allergic rhinitis	2.54e-05	0.000219	CcSEcCtD
Tacrolimus—Vertigo—Dexamethasone—allergic rhinitis	2.54e-05	0.000219	CcSEcCtD
Tacrolimus—Vertigo—Betamethasone—allergic rhinitis	2.54e-05	0.000219	CcSEcCtD
Tacrolimus—Anaphylactic shock—Methylprednisolone—allergic rhinitis	2.53e-05	0.000218	CcSEcCtD
Tacrolimus—Syncope—Dexamethasone—allergic rhinitis	2.53e-05	0.000218	CcSEcCtD
Tacrolimus—Syncope—Betamethasone—allergic rhinitis	2.53e-05	0.000218	CcSEcCtD
Tacrolimus—Infection—Triamcinolone—allergic rhinitis	2.52e-05	0.000217	CcSEcCtD
Tacrolimus—Hypotension—Hydrocortisone—allergic rhinitis	2.52e-05	0.000217	CcSEcCtD
Tacrolimus—Infection—Methylprednisolone—allergic rhinitis	2.52e-05	0.000217	CcSEcCtD
Tacrolimus—Shock—Triamcinolone—allergic rhinitis	2.5e-05	0.000215	CcSEcCtD
Tacrolimus—Insomnia—Prednisolone—allergic rhinitis	2.5e-05	0.000215	CcSEcCtD
Tacrolimus—Shock—Methylprednisolone—allergic rhinitis	2.49e-05	0.000215	CcSEcCtD
Tacrolimus—Nervous system disorder—Methylprednisolone—allergic rhinitis	2.48e-05	0.000214	CcSEcCtD
Tacrolimus—Loss of consciousness—Dexamethasone—allergic rhinitis	2.48e-05	0.000214	CcSEcCtD
Tacrolimus—Loss of consciousness—Betamethasone—allergic rhinitis	2.48e-05	0.000214	CcSEcCtD
Tacrolimus—Paraesthesia—Prednisolone—allergic rhinitis	2.48e-05	0.000214	CcSEcCtD
Tacrolimus—Tachycardia—Triamcinolone—allergic rhinitis	2.48e-05	0.000214	CcSEcCtD
Tacrolimus—Tachycardia—Methylprednisolone—allergic rhinitis	2.47e-05	0.000213	CcSEcCtD
Tacrolimus—Skin disorder—Methylprednisolone—allergic rhinitis	2.46e-05	0.000212	CcSEcCtD
Tacrolimus—Musculoskeletal discomfort—Hydrocortisone—allergic rhinitis	2.46e-05	0.000212	CcSEcCtD
Tacrolimus—Hyperhidrosis—Triamcinolone—allergic rhinitis	2.45e-05	0.000211	CcSEcCtD
Tacrolimus—Hyperhidrosis—Methylprednisolone—allergic rhinitis	2.45e-05	0.000211	CcSEcCtD
Tacrolimus—Convulsion—Betamethasone—allergic rhinitis	2.45e-05	0.000211	CcSEcCtD
Tacrolimus—Convulsion—Dexamethasone—allergic rhinitis	2.45e-05	0.000211	CcSEcCtD
Tacrolimus—PPP3CA—Disease—SMAD3—allergic rhinitis	2.44e-05	0.002	CbGpPWpGaD
Tacrolimus—Insomnia—Hydrocortisone—allergic rhinitis	2.44e-05	0.00021	CcSEcCtD
Tacrolimus—Hypertension—Dexamethasone—allergic rhinitis	2.44e-05	0.00021	CcSEcCtD
Tacrolimus—Hypertension—Betamethasone—allergic rhinitis	2.44e-05	0.00021	CcSEcCtD
Tacrolimus—PPP3CA—Signaling Pathways—IL5—allergic rhinitis	2.43e-05	0.00199	CbGpPWpGaD
Tacrolimus—Paraesthesia—Hydrocortisone—allergic rhinitis	2.42e-05	0.000209	CcSEcCtD
Tacrolimus—Myalgia—Dexamethasone—allergic rhinitis	2.4e-05	0.000207	CcSEcCtD
Tacrolimus—Myalgia—Betamethasone—allergic rhinitis	2.4e-05	0.000207	CcSEcCtD
Tacrolimus—MTOR—B Cell Activation—NFKB1—allergic rhinitis	2.4e-05	0.00196	CbGpPWpGaD
Tacrolimus—Anxiety—Betamethasone—allergic rhinitis	2.4e-05	0.000206	CcSEcCtD
Tacrolimus—Anxiety—Dexamethasone—allergic rhinitis	2.4e-05	0.000206	CcSEcCtD
Tacrolimus—Discomfort—Dexamethasone—allergic rhinitis	2.37e-05	0.000205	CcSEcCtD
Tacrolimus—Discomfort—Betamethasone—allergic rhinitis	2.37e-05	0.000205	CcSEcCtD
Tacrolimus—Dyspepsia—Hydrocortisone—allergic rhinitis	2.37e-05	0.000205	CcSEcCtD
Tacrolimus—Hypotension—Methylprednisolone—allergic rhinitis	2.37e-05	0.000204	CcSEcCtD
Tacrolimus—Pain—Prednisolone—allergic rhinitis	2.36e-05	0.000203	CcSEcCtD
Tacrolimus—Decreased appetite—Hydrocortisone—allergic rhinitis	2.34e-05	0.000202	CcSEcCtD
Tacrolimus—Gastrointestinal disorder—Hydrocortisone—allergic rhinitis	2.33e-05	0.000201	CcSEcCtD
Tacrolimus—Fatigue—Hydrocortisone—allergic rhinitis	2.33e-05	0.0002	CcSEcCtD
Tacrolimus—Musculoskeletal discomfort—Triamcinolone—allergic rhinitis	2.31e-05	0.000199	CcSEcCtD
Tacrolimus—Musculoskeletal discomfort—Methylprednisolone—allergic rhinitis	2.31e-05	0.000199	CcSEcCtD
Tacrolimus—PPP3CA—Innate Immune System—NFKB1—allergic rhinitis	2.31e-05	0.00189	CbGpPWpGaD
Tacrolimus—Pain—Hydrocortisone—allergic rhinitis	2.31e-05	0.000199	CcSEcCtD
Tacrolimus—Anaphylactic shock—Dexamethasone—allergic rhinitis	2.3e-05	0.000198	CcSEcCtD
Tacrolimus—Oedema—Dexamethasone—allergic rhinitis	2.3e-05	0.000198	CcSEcCtD
Tacrolimus—Anaphylactic shock—Betamethasone—allergic rhinitis	2.3e-05	0.000198	CcSEcCtD
Tacrolimus—Oedema—Betamethasone—allergic rhinitis	2.3e-05	0.000198	CcSEcCtD
Tacrolimus—Insomnia—Triamcinolone—allergic rhinitis	2.3e-05	0.000198	CcSEcCtD
Tacrolimus—Insomnia—Methylprednisolone—allergic rhinitis	2.29e-05	0.000197	CcSEcCtD
Tacrolimus—Infection—Dexamethasone—allergic rhinitis	2.29e-05	0.000197	CcSEcCtD
Tacrolimus—Infection—Betamethasone—allergic rhinitis	2.29e-05	0.000197	CcSEcCtD
Tacrolimus—Paraesthesia—Triamcinolone—allergic rhinitis	2.28e-05	0.000196	CcSEcCtD
Tacrolimus—Feeling abnormal—Prednisolone—allergic rhinitis	2.28e-05	0.000196	CcSEcCtD
Tacrolimus—Paraesthesia—Methylprednisolone—allergic rhinitis	2.28e-05	0.000196	CcSEcCtD
Tacrolimus—Shock—Betamethasone—allergic rhinitis	2.27e-05	0.000195	CcSEcCtD
Tacrolimus—Shock—Dexamethasone—allergic rhinitis	2.27e-05	0.000195	CcSEcCtD
Tacrolimus—Dyspnoea—Triamcinolone—allergic rhinitis	2.26e-05	0.000195	CcSEcCtD
Tacrolimus—Nervous system disorder—Dexamethasone—allergic rhinitis	2.26e-05	0.000195	CcSEcCtD
Tacrolimus—Nervous system disorder—Betamethasone—allergic rhinitis	2.26e-05	0.000195	CcSEcCtD
Tacrolimus—Thrombocytopenia—Dexamethasone—allergic rhinitis	2.26e-05	0.000194	CcSEcCtD
Tacrolimus—Thrombocytopenia—Betamethasone—allergic rhinitis	2.26e-05	0.000194	CcSEcCtD
Tacrolimus—Tachycardia—Dexamethasone—allergic rhinitis	2.25e-05	0.000194	CcSEcCtD
Tacrolimus—Tachycardia—Betamethasone—allergic rhinitis	2.25e-05	0.000194	CcSEcCtD
Tacrolimus—Dyspepsia—Triamcinolone—allergic rhinitis	2.24e-05	0.000193	CcSEcCtD
Tacrolimus—Dyspepsia—Methylprednisolone—allergic rhinitis	2.23e-05	0.000192	CcSEcCtD
Tacrolimus—Hyperhidrosis—Betamethasone—allergic rhinitis	2.23e-05	0.000192	CcSEcCtD
Tacrolimus—Hyperhidrosis—Dexamethasone—allergic rhinitis	2.23e-05	0.000192	CcSEcCtD
Tacrolimus—ALB—Selenium Micronutrient Network—NFKB1—allergic rhinitis	2.23e-05	0.00182	CbGpPWpGaD
Tacrolimus—Feeling abnormal—Hydrocortisone—allergic rhinitis	2.22e-05	0.000191	CcSEcCtD
Tacrolimus—Gastrointestinal pain—Hydrocortisone—allergic rhinitis	2.21e-05	0.00019	CcSEcCtD
Tacrolimus—Anorexia—Betamethasone—allergic rhinitis	2.2e-05	0.000189	CcSEcCtD
Tacrolimus—Anorexia—Dexamethasone—allergic rhinitis	2.2e-05	0.000189	CcSEcCtD
Tacrolimus—Urticaria—Prednisolone—allergic rhinitis	2.19e-05	0.000189	CcSEcCtD
Tacrolimus—Fatigue—Triamcinolone—allergic rhinitis	2.19e-05	0.000189	CcSEcCtD
Tacrolimus—Fatigue—Methylprednisolone—allergic rhinitis	2.18e-05	0.000188	CcSEcCtD
Tacrolimus—Pain—Triamcinolone—allergic rhinitis	2.17e-05	0.000187	CcSEcCtD
Tacrolimus—Hypotension—Betamethasone—allergic rhinitis	2.15e-05	0.000185	CcSEcCtD
Tacrolimus—Hypotension—Dexamethasone—allergic rhinitis	2.15e-05	0.000185	CcSEcCtD
Tacrolimus—Urticaria—Hydrocortisone—allergic rhinitis	2.14e-05	0.000185	CcSEcCtD
Tacrolimus—Abdominal pain—Hydrocortisone—allergic rhinitis	2.13e-05	0.000184	CcSEcCtD
Tacrolimus—Body temperature increased—Hydrocortisone—allergic rhinitis	2.13e-05	0.000184	CcSEcCtD
Tacrolimus—PPP3CA—Immune System—ICAM1—allergic rhinitis	2.12e-05	0.00174	CbGpPWpGaD
Tacrolimus—Musculoskeletal discomfort—Betamethasone—allergic rhinitis	2.1e-05	0.000181	CcSEcCtD
Tacrolimus—Musculoskeletal discomfort—Dexamethasone—allergic rhinitis	2.1e-05	0.000181	CcSEcCtD
Tacrolimus—Feeling abnormal—Triamcinolone—allergic rhinitis	2.09e-05	0.00018	CcSEcCtD
Tacrolimus—MTOR—Adaptive Immune System—HLA-DQB1—allergic rhinitis	2.09e-05	0.00171	CbGpPWpGaD
Tacrolimus—Feeling abnormal—Methylprednisolone—allergic rhinitis	2.09e-05	0.00018	CcSEcCtD
Tacrolimus—Insomnia—Betamethasone—allergic rhinitis	2.08e-05	0.00018	CcSEcCtD
Tacrolimus—Insomnia—Dexamethasone—allergic rhinitis	2.08e-05	0.00018	CcSEcCtD
Tacrolimus—Gastrointestinal pain—Methylprednisolone—allergic rhinitis	2.07e-05	0.000178	CcSEcCtD
Tacrolimus—MTOR—Signaling Pathways—PTGDR2—allergic rhinitis	2.07e-05	0.00169	CbGpPWpGaD
Tacrolimus—Paraesthesia—Betamethasone—allergic rhinitis	2.07e-05	0.000178	CcSEcCtD
Tacrolimus—Paraesthesia—Dexamethasone—allergic rhinitis	2.07e-05	0.000178	CcSEcCtD
Tacrolimus—Hypersensitivity—Prednisolone—allergic rhinitis	2.03e-05	0.000175	CcSEcCtD
Tacrolimus—MTOR—Immune System—HLA-G—allergic rhinitis	2.03e-05	0.00166	CbGpPWpGaD
Tacrolimus—Dyspepsia—Dexamethasone—allergic rhinitis	2.03e-05	0.000175	CcSEcCtD
Tacrolimus—Dyspepsia—Betamethasone—allergic rhinitis	2.03e-05	0.000175	CcSEcCtD
Tacrolimus—FKBP1A—Signaling Pathways—TAC1—allergic rhinitis	2.03e-05	0.00166	CbGpPWpGaD
Tacrolimus—Urticaria—Triamcinolone—allergic rhinitis	2.02e-05	0.000174	CcSEcCtD
Tacrolimus—Urticaria—Methylprednisolone—allergic rhinitis	2.01e-05	0.000173	CcSEcCtD
Tacrolimus—Body temperature increased—Triamcinolone—allergic rhinitis	2.01e-05	0.000173	CcSEcCtD
Tacrolimus—Abdominal pain—Methylprednisolone—allergic rhinitis	2e-05	0.000173	CcSEcCtD
Tacrolimus—Decreased appetite—Betamethasone—allergic rhinitis	2e-05	0.000173	CcSEcCtD
Tacrolimus—Decreased appetite—Dexamethasone—allergic rhinitis	2e-05	0.000173	CcSEcCtD
Tacrolimus—ALB—Platelet degranulation—TGFB1—allergic rhinitis	2e-05	0.00164	CbGpPWpGaD
Tacrolimus—Gastrointestinal disorder—Dexamethasone—allergic rhinitis	1.99e-05	0.000171	CcSEcCtD
Tacrolimus—Gastrointestinal disorder—Betamethasone—allergic rhinitis	1.99e-05	0.000171	CcSEcCtD
Tacrolimus—Hypersensitivity—Hydrocortisone—allergic rhinitis	1.99e-05	0.000171	CcSEcCtD
Tacrolimus—Fatigue—Dexamethasone—allergic rhinitis	1.99e-05	0.000171	CcSEcCtD
Tacrolimus—Fatigue—Betamethasone—allergic rhinitis	1.99e-05	0.000171	CcSEcCtD
Tacrolimus—Pain—Dexamethasone—allergic rhinitis	1.97e-05	0.00017	CcSEcCtD
Tacrolimus—Pain—Betamethasone—allergic rhinitis	1.97e-05	0.00017	CcSEcCtD
Tacrolimus—Asthenia—Hydrocortisone—allergic rhinitis	1.94e-05	0.000167	CcSEcCtD
Tacrolimus—Pruritus—Hydrocortisone—allergic rhinitis	1.91e-05	0.000164	CcSEcCtD
Tacrolimus—ALB—Response to elevated platelet cytosolic Ca2+—TGFB1—allergic rhinitis	1.91e-05	0.00156	CbGpPWpGaD
Tacrolimus—Feeling abnormal—Betamethasone—allergic rhinitis	1.9e-05	0.000164	CcSEcCtD
Tacrolimus—Feeling abnormal—Dexamethasone—allergic rhinitis	1.9e-05	0.000164	CcSEcCtD
Tacrolimus—FKBP1A—Disease—SMAD3—allergic rhinitis	1.89e-05	0.00155	CbGpPWpGaD
Tacrolimus—Gastrointestinal pain—Betamethasone—allergic rhinitis	1.88e-05	0.000162	CcSEcCtD
Tacrolimus—Gastrointestinal pain—Dexamethasone—allergic rhinitis	1.88e-05	0.000162	CcSEcCtD
Tacrolimus—FKBP1A—Signaling Pathways—IL5—allergic rhinitis	1.88e-05	0.00154	CbGpPWpGaD
Tacrolimus—MTOR—Cellular responses to stress—NFKB1—allergic rhinitis	1.88e-05	0.00154	CbGpPWpGaD
Tacrolimus—Hypersensitivity—Triamcinolone—allergic rhinitis	1.87e-05	0.000161	CcSEcCtD
Tacrolimus—Hypersensitivity—Methylprednisolone—allergic rhinitis	1.87e-05	0.000161	CcSEcCtD
Tacrolimus—Diarrhoea—Hydrocortisone—allergic rhinitis	1.85e-05	0.000159	CcSEcCtD
Tacrolimus—Urticaria—Betamethasone—allergic rhinitis	1.83e-05	0.000158	CcSEcCtD
Tacrolimus—Urticaria—Dexamethasone—allergic rhinitis	1.83e-05	0.000158	CcSEcCtD
Tacrolimus—Dizziness—Prednisolone—allergic rhinitis	1.83e-05	0.000157	CcSEcCtD
Tacrolimus—Asthenia—Triamcinolone—allergic rhinitis	1.82e-05	0.000157	CcSEcCtD
Tacrolimus—Body temperature increased—Dexamethasone—allergic rhinitis	1.82e-05	0.000157	CcSEcCtD
Tacrolimus—Abdominal pain—Betamethasone—allergic rhinitis	1.82e-05	0.000157	CcSEcCtD
Tacrolimus—Abdominal pain—Dexamethasone—allergic rhinitis	1.82e-05	0.000157	CcSEcCtD
Tacrolimus—Body temperature increased—Betamethasone—allergic rhinitis	1.82e-05	0.000157	CcSEcCtD
Tacrolimus—Asthenia—Methylprednisolone—allergic rhinitis	1.82e-05	0.000157	CcSEcCtD
Tacrolimus—Pruritus—Triamcinolone—allergic rhinitis	1.8e-05	0.000155	CcSEcCtD
Tacrolimus—Pruritus—Methylprednisolone—allergic rhinitis	1.79e-05	0.000154	CcSEcCtD
Tacrolimus—Dizziness—Hydrocortisone—allergic rhinitis	1.78e-05	0.000154	CcSEcCtD
Tacrolimus—ABCB1—Allograft Rejection—TGFB1—allergic rhinitis	1.77e-05	0.00145	CbGpPWpGaD
Tacrolimus—MTOR—Signaling by NGF—NFKB1—allergic rhinitis	1.76e-05	0.00144	CbGpPWpGaD
Tacrolimus—Rash—Prednisolone—allergic rhinitis	1.74e-05	0.00015	CcSEcCtD
Tacrolimus—Dermatitis—Prednisolone—allergic rhinitis	1.74e-05	0.00015	CcSEcCtD
Tacrolimus—Diarrhoea—Methylprednisolone—allergic rhinitis	1.73e-05	0.000149	CcSEcCtD
Tacrolimus—Headache—Prednisolone—allergic rhinitis	1.73e-05	0.000149	CcSEcCtD
Tacrolimus—Vomiting—Hydrocortisone—allergic rhinitis	1.71e-05	0.000148	CcSEcCtD
Tacrolimus—PPP3CA—Signaling Pathways—SMAD3—allergic rhinitis	1.71e-05	0.0014	CbGpPWpGaD
Tacrolimus—Rash—Hydrocortisone—allergic rhinitis	1.7e-05	0.000146	CcSEcCtD
Tacrolimus—Dermatitis—Hydrocortisone—allergic rhinitis	1.7e-05	0.000146	CcSEcCtD
Tacrolimus—Headache—Hydrocortisone—allergic rhinitis	1.69e-05	0.000146	CcSEcCtD
Tacrolimus—Dizziness—Triamcinolone—allergic rhinitis	1.68e-05	0.000145	CcSEcCtD
Tacrolimus—Dizziness—Methylprednisolone—allergic rhinitis	1.68e-05	0.000144	CcSEcCtD
Tacrolimus—Asthenia—Dexamethasone—allergic rhinitis	1.65e-05	0.000142	CcSEcCtD
Tacrolimus—Asthenia—Betamethasone—allergic rhinitis	1.65e-05	0.000142	CcSEcCtD
Tacrolimus—Nausea—Prednisolone—allergic rhinitis	1.64e-05	0.000141	CcSEcCtD
Tacrolimus—MTOR—Immune System—IL5—allergic rhinitis	1.64e-05	0.00134	CbGpPWpGaD
Tacrolimus—Pruritus—Betamethasone—allergic rhinitis	1.63e-05	0.00014	CcSEcCtD
Tacrolimus—Pruritus—Dexamethasone—allergic rhinitis	1.63e-05	0.00014	CcSEcCtD
Tacrolimus—MTOR—Signaling Pathways—CYSLTR1—allergic rhinitis	1.62e-05	0.00133	CbGpPWpGaD
Tacrolimus—Vomiting—Triamcinolone—allergic rhinitis	1.61e-05	0.000139	CcSEcCtD
Tacrolimus—Vomiting—Methylprednisolone—allergic rhinitis	1.61e-05	0.000139	CcSEcCtD
Tacrolimus—Nausea—Hydrocortisone—allergic rhinitis	1.6e-05	0.000138	CcSEcCtD
Tacrolimus—Rash—Triamcinolone—allergic rhinitis	1.6e-05	0.000138	CcSEcCtD
Tacrolimus—Dermatitis—Triamcinolone—allergic rhinitis	1.6e-05	0.000138	CcSEcCtD
Tacrolimus—Rash—Methylprednisolone—allergic rhinitis	1.6e-05	0.000138	CcSEcCtD
Tacrolimus—Dermatitis—Methylprednisolone—allergic rhinitis	1.6e-05	0.000137	CcSEcCtD
Tacrolimus—Headache—Triamcinolone—allergic rhinitis	1.59e-05	0.000137	CcSEcCtD
Tacrolimus—Headache—Methylprednisolone—allergic rhinitis	1.59e-05	0.000137	CcSEcCtD
Tacrolimus—Diarrhoea—Betamethasone—allergic rhinitis	1.58e-05	0.000136	CcSEcCtD
Tacrolimus—Diarrhoea—Dexamethasone—allergic rhinitis	1.58e-05	0.000136	CcSEcCtD
Tacrolimus—MTOR—Signaling Pathways—CCL11—allergic rhinitis	1.57e-05	0.00128	CbGpPWpGaD
Tacrolimus—PPP3CA—Immune System—CD4—allergic rhinitis	1.56e-05	0.00128	CbGpPWpGaD
Tacrolimus—ALB—Hemostasis—IL5—allergic rhinitis	1.54e-05	0.00126	CbGpPWpGaD
Tacrolimus—MTOR—Adaptive Immune System—ICAM1—allergic rhinitis	1.53e-05	0.00125	CbGpPWpGaD
Tacrolimus—Dizziness—Dexamethasone—allergic rhinitis	1.52e-05	0.000131	CcSEcCtD
Tacrolimus—Dizziness—Betamethasone—allergic rhinitis	1.52e-05	0.000131	CcSEcCtD
Tacrolimus—Nausea—Triamcinolone—allergic rhinitis	1.51e-05	0.00013	CcSEcCtD
Tacrolimus—Nausea—Methylprednisolone—allergic rhinitis	1.51e-05	0.00013	CcSEcCtD
Tacrolimus—Vomiting—Betamethasone—allergic rhinitis	1.47e-05	0.000126	CcSEcCtD
Tacrolimus—Vomiting—Dexamethasone—allergic rhinitis	1.47e-05	0.000126	CcSEcCtD
Tacrolimus—Rash—Dexamethasone—allergic rhinitis	1.45e-05	0.000125	CcSEcCtD
Tacrolimus—Rash—Betamethasone—allergic rhinitis	1.45e-05	0.000125	CcSEcCtD
Tacrolimus—Dermatitis—Betamethasone—allergic rhinitis	1.45e-05	0.000125	CcSEcCtD
Tacrolimus—Dermatitis—Dexamethasone—allergic rhinitis	1.45e-05	0.000125	CcSEcCtD
Tacrolimus—Headache—Betamethasone—allergic rhinitis	1.44e-05	0.000124	CcSEcCtD
Tacrolimus—Headache—Dexamethasone—allergic rhinitis	1.44e-05	0.000124	CcSEcCtD
Tacrolimus—PPP3CA—Disease—CD4—allergic rhinitis	1.44e-05	0.00118	CbGpPWpGaD
Tacrolimus—Nausea—Betamethasone—allergic rhinitis	1.37e-05	0.000118	CcSEcCtD
Tacrolimus—Nausea—Dexamethasone—allergic rhinitis	1.37e-05	0.000118	CcSEcCtD
Tacrolimus—PPP3CA—Immune System—NFKB1—allergic rhinitis	1.34e-05	0.0011	CbGpPWpGaD
Tacrolimus—FKBP1A—Signaling Pathways—SMAD3—allergic rhinitis	1.33e-05	0.00109	CbGpPWpGaD
Tacrolimus—MTOR—Immune System—HLA-DQB1—allergic rhinitis	1.27e-05	0.00104	CbGpPWpGaD
Tacrolimus—MTOR—Innate Immune System—CD4—allergic rhinitis	1.17e-05	0.000956	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—TAC1—allergic rhinitis	1.14e-05	0.000933	CbGpPWpGaD
Tacrolimus—MTOR—Adaptive Immune System—CD4—allergic rhinitis	1.12e-05	0.000918	CbGpPWpGaD
Tacrolimus—FKBP1A—Disease—CD4—allergic rhinitis	1.12e-05	0.000914	CbGpPWpGaD
Tacrolimus—MTOR—Disease—SMAD3—allergic rhinitis	1.06e-05	0.000872	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—IL5—allergic rhinitis	1.06e-05	0.000867	CbGpPWpGaD
Tacrolimus—ABCB1—Integrated Pancreatic Cancer Pathway—NFKB1—allergic rhinitis	1.05e-05	0.000859	CbGpPWpGaD
Tacrolimus—PPP3CA—Disease—TGFB1—allergic rhinitis	1.03e-05	0.000846	CbGpPWpGaD
Tacrolimus—MTOR—Innate Immune System—NFKB1—allergic rhinitis	1.01e-05	0.000824	CbGpPWpGaD
Tacrolimus—MTOR—Adaptive Immune System—NFKB1—allergic rhinitis	9.67e-06	0.000791	CbGpPWpGaD
Tacrolimus—MTOR—Immune System—ICAM1—allergic rhinitis	9.26e-06	0.000758	CbGpPWpGaD
Tacrolimus—ALB—Platelet activation, signaling and aggregation—TGFB1—allergic rhinitis	8.88e-06	0.000727	CbGpPWpGaD
Tacrolimus—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—allergic rhinitis	8.74e-06	0.000716	CbGpPWpGaD
Tacrolimus—PPP3CA—Signaling Pathways—NFKB1—allergic rhinitis	8.69e-06	0.000712	CbGpPWpGaD
Tacrolimus—FKBP1A—Disease—TGFB1—allergic rhinitis	8.02e-06	0.000656	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—SMAD3—allergic rhinitis	7.46e-06	0.00061	CbGpPWpGaD
Tacrolimus—PPP3CA—Signaling Pathways—TGFB1—allergic rhinitis	7.24e-06	0.000593	CbGpPWpGaD
Tacrolimus—MTOR—Immune System—CD4—allergic rhinitis	6.8e-06	0.000557	CbGpPWpGaD
Tacrolimus—FKBP1A—Signaling Pathways—NFKB1—allergic rhinitis	6.74e-06	0.000552	CbGpPWpGaD
Tacrolimus—MTOR—Disease—CD4—allergic rhinitis	6.28e-06	0.000514	CbGpPWpGaD
Tacrolimus—MTOR—Immune System—NFKB1—allergic rhinitis	5.86e-06	0.00048	CbGpPWpGaD
Tacrolimus—FKBP1A—Signaling Pathways—TGFB1—allergic rhinitis	5.61e-06	0.00046	CbGpPWpGaD
Tacrolimus—ALB—Hemostasis—TGFB1—allergic rhinitis	4.58e-06	0.000375	CbGpPWpGaD
Tacrolimus—MTOR—Disease—TGFB1—allergic rhinitis	4.51e-06	0.000369	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—NFKB1—allergic rhinitis	3.79e-06	0.00031	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—TGFB1—allergic rhinitis	3.16e-06	0.000258	CbGpPWpGaD
